Posts Tagged: Cell & Tissue Engineering
In the 4th volume of Nature’s Communications Biology, researchers at TBEP published an important study that can reshape the way we engineer new blood vessels for patients who need them.
A new technology developed by researchers at the University of Toronto provides the first step in mimicking the environment of lung airways, enables scientists to perform particle exposure experiments to examine the pathological effect of air pollutants on respiratory health.
The science of rapid wound healing has new insights due to discoveries in fruit flies from the Fernandez-Gonzalez lab at University of Toronto. Collaboration, community and perseverance has resulted in an article published in the journal Cell Reports as “p38-mediated cell growth and survival drive rapid embryonic wound repair”.
Scientists out of two labs at the University of Toronto have discovered a novel way to test self-repair of skeletal muscle, and this method has the potential to rapidly advance the development of treatments for diseases like muscular dystrophy (MD) and other degenerative muscle conditions.
Professor Craig Simmons was inducted as a Biomedical Engineering Society (BMES) fellow among 19 other internationally recognized scientists and engineers. As a BMES fellow, Dr. Simmons was recognized internationally for his innovative and wide-ranging contributions to both fundamental science and practical applications in the field of mechanobiology.
Drs. Cristina Nostro and Sara Nunes Vasconcelos, with their postdoctoral fellow Dr. Yasaman Aghazadeh, have engineered a new method to improve the survival and potency of such cell transplants.
Michael Sefton, a U of T tissue engineer and executive director of Medicine by Design, is investigating whether dendritic skin cells can aid in the successful transplantation of insulin-producing islet cells in diabetes patients.
In a recent study, researchers from the University of Toronto employed a unique state-of-the-art imaging technique for deep tissue imaging, that has enabled the monitoring of peri-implant bony healing biology in action. This technology can lead to a better understanding of the healing process, allowing researchers to leverage this knowledge to develop faster therapeutic approaches with the use of biomaterials for the future.
An innovative biomaterial discovery by researchers at the University of Toronto in collaboration with Ripple Therapeutics Inc., has established a method that yields better control over drug release profiles in implants and has the potential to disrupt the classical drug delivery market.
Showing 51 - 60 of 105 results